SCHEMBL14036694

SCHEMBL14036694

Cc1cc(C)c(C(C)N)cc1C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
LMNA P02545 2/20 0.38
TP53 P04637 1/20 0.38
HTT P42858 1/20 0.38
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 1/20 0.33
NFKB1 P19838 1/20 0.33
PDE2A O00408 1/20 0.33
PNMT P11086 1/20 0.33
ALDH1A1 P00352 2/20 0.32
GLA P06280 1/20 0.32
GRM1 Q13255 3/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18917026 0.94 LMNA (0.41) CYP3A4TSHRMAPK1LMNATP53
SCHEMBL9493682 0.92 LMNA (0.39) CYP3A4TSHRMAPK1LMNATP53
SCHEMBL1753957 0.80 KDM4E (0.46) CYP3A4TSHRMAPK1LMNATP53
SCHEMBL754453 0.80 CYP3A4 (0.41) CYP3A4TSHRMAPK1CYP1A2ALDH1A1
Hydrochloric Acid SCHEMBL10782102 0.78 CYP3A4 (0.39) CYP3A4TSHRMAPK1CYP1A2ALDH1A1
SCHEMBL14378407 0.77 PDE2A (0.47) CYP3A4LMNATP53HTTCYP1A2
SCHEMBL1754168 0.77 POLB (0.47) CYP2D6
SCHEMBL20969672 0.77 POLB (0.47) CYP2D6
SCHEMBL1753939 0.77 POLB (0.47) CYP2D6
SCHEMBL4972071 0.77 LMNA (0.39) CYP3A4TSHRMAPK1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3412660-B1 SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME EA PHARMA CO LTD (JP) 2020-11-18 EP disclosed
WO-2008137102-A2 METHODS OF MODULATING AMYLOID BETA AND COMPOUNDS USEFUL THEREFOR TORREYPINES THERAPEUTICS, INC. (US) 2008-11-13 WO disclosed